When, and how, should we introduce a combination measles-mumps-rubella (MMR) vaccine into the national childhood expanded immunization programme in South Africa?

Vaccine

Volumn 30, Issue SUPPL.3, 2012, Pages

  Cameron, Neil A ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Congenital rubella syndrome; Elimination of measles and rubella; Immunization programmes; MMR vaccine

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

CHILD HEALTH CARE; CONGENITAL RUBELLA SYNDROME; DISEASE CONTROL; DISEASE SURVEILLANCE; DRUG COST; DRUG EFFICACY; EPIDEMIC; ERADICATION THERAPY; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION SENSITIVITY; INTENSIVE CARE; MEASLES; MORTALITY; MUMPS; ORCHITIS; PAROTITIS; POLIOMYELITIS; PRIMARY HEALTH CARE; PRIORITY JOURNAL; REVIEW; RUBELLA; SEROPREVALENCE; SOUTH AFRICA; VIRUS MENINGITIS; WORLD HEALTH ORGANIZATION;

DISEASE ERADICATION; FEMALE; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; RUBELLA; SOUTH AFRICA;

EID: 84865662619     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.082     Document Type: Review

References (30)

1. Centers for Disease Control and Prevention Epidemiology and prevention of vaccine-preventable diseases 2011, Public Health Foundation, Washington, DC. http://www.cdc.gov/vaccines/pubs/pinkbook, 12th ed. W. Atkinson, S. Wolfe, J. Hamborsky (Eds.).
2. Drutz J.E. Measles: its history and its eventual eradication. Semin Pediatr Infect Dis 2001, 12(4):315-322.
3. Morley D.C. Severe measles in the tropics. 1. BMJ 1969, (1):297-300.
4. Control of communicable disease manual 2004, APHA. 18th ed. D.L. Heyman (Ed.).
5. World Health Organization, Global Eradication of Measles. Report by the secretariat sixty-third world health assembly A63/18. Provisional agenda item 11.15; 25 March 2010.
6. Küstner H.G.V., Radloff A.M. The measles strategy revisited-what happened?. Epidemiol Comments 1993, 20(9):2-22. Department of Health, South Africa.
7. National review of the South African National Immunization Programme. Epidemiol Comments 1994, 21(10):204-215. Department of Health, South Africa.
8. McMorrow M.L., van den Heever J. Measles outbreak in South Africa, 2003-2005. S Afr Med J 2009, 99:314-319.
9. Communicable Diseases Surveillance Bulletins of the National Institute for Communicable Diseases. Compiled from tables: provisional listing of laboratory confirmed cases of disease reported respectively for the years 2006, 2007 and 2008 in the March edition of the Bulletin of the following year. http://www.nicd.ac.za/assets/files/CommDisBull.
10. Measles. National Institute for Communicable Disease, Communiqué May 2011(2) Communiqué-May 2011(2) [Accessed July 2011]. http://www.nicd.ac.za/assets/files/NICD-NHLS.
11. Measles and Diarrhoea Death Toll Hits 16. Cape Argus 15 March 2010 [accessed November 2011]. http://allafrica.com/stories/201003160074.html.
12. Volmink H., Ihekweazu C. Report on symposium to review the recent measles outbreak in South Africa 2009-2011 2011, National Institute for Communicable Diseases, 19 May 2011.
13. Galazka A.M., Robertson S.E., Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ 1999, 77(1):3-14.
14. Hviid A., Rubin S., Mühlemann K. Mumps. Lancet 2008, 371(9616):932-944.
15. McIntyre J.P., Keen G. Laboratory surveillance of viral meningitis by examination of cerebrospinal fluid in Cape Town, 1981-9. Epidemiol Infect 1993, 111:357-371.
16. Australian dictionary of biography 1996, vol. 14. Melbourne University Press, p. 325-7. http://adbonline.anu.edu.au/biogs/A140370b.htm [Accessed July 2011].
17. Rubella vaccines, World Health Organization. Wkly Epidemiol Rec 2000, 75:161-169.
18. Schoub B.D., Harris B.N., McAnerney J., Blumberg L.S. Rubella in South Africa: an impending Greek tragedy. S Afr Med J 2009, 99:515-519.
19. Menser M.A., Forrest J.M. Rubella-high incidence of defects in children considered normal at birth. Med J Aust 1974, 1(5):123-126.
20. Hinman A.R., Irons B., Lewis M., Kandola K. Economic analysis of rubella and rubella vaccines: a global review. Bull World Health Organ 2002, 80:264-270.
21. UNICEF tender prices [Accessed July 2011]. http://www.unicef.org/supply/index_57476.html.
22. Reef S.E., Strebel P., Dabbagh A., Gacic-Dobo M., Cochi S. Progress towards the control of rubella and prevention of congenital rubella syndrome-worldwide 2009. J Infect Dis 2011, 204(Suppl. 1).
23. Panagiotopoulos T., Antoniadou I., Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. Br Med J 1999, 319:1462-1467.
24. Lanzieri T.M., Segatto T.C., Siqueira M.M., Marilda M., Santos E.C., De Oliveira M.D., et al. Burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001. Pediatr Infect Dis J 2003, 22:323-329.
25. Vynnycky E., Gay N.J., Cutts F.T. The predicted impact of private sector MMR vaccination on the burden of congenital rubella syndrome. Vaccine 2003, 21(21-22):2708-2719.
26. Larson H.J., Cooper L.Z., Eskola J., Katz S.L., Ratzan S. Addressing the vaccine confidence gap. Lancet 2011, 378(August):26-35.
27. Leach M., Fairhead J. Vaccine anxieties, global sciences, child health and society. Earth Scan 2007, ISBN-13:978-1-84407-370-2.
28. Rubella watch (PAHO) January-April 2011. [accessed August 2011]. http://new.paho.org/hq/dmdocuments/2011/NL_RubellaWatch2011_01e.pdf.
29. World Health Organization. Recommended standards for surveillance of selected vaccine-preventable diseases. [accessed April 2011]. http://www.who.int/vaccines-documents/DocsPDF06/843.pdf.
30. Re-Engineering Primary Health Care. Speech by the Minister of Health at the Launch of the SA/EU Primary Health Care Sector Policy Support Programme. 14 September 2011 [Accessed February 2012]. http://www.doh.gov.za/show.php?id=3067.